The increased expression of HO-1 has been observed in several cancers including brain tumor, melanoma, chronic myeloid leukemia, and lymphosarcoma [12], suggesting possible contribution of HO-1 to tumor progression through promotion of angiogenesis, metastases and pro-proliferation [13]. Here, HMOX1 is linked to melanoma.